미생물 발효 기술 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2023-2031년)

Microbial Fermentation Technology Market - Scope of Report

TMR's report on the global microbial fermentation technology market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global microbial fermentation technology market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global microbial fermentation technology market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the microbial fermentation technology market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global microbial fermentation technology market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global microbial fermentation technology market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global microbial fermentation technology market.

The report delves into the competitive landscape of the global microbial fermentation technology market. Key players operating in the global microbial fermentation technology market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global microbial fermentation technology market profiled in this report.

Key Questions Answered in Global microbial fermentation technology Market Report:

• What is the sales/revenue generated by microbial fermentation technology across all regions during the forecast period?
• What are the opportunities in the global microbial fermentation technology market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Microbial Fermentation Technology Market - Research Objectives and Research Approach

The comprehensive report on the global microbial fermentation technology market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global microbial fermentation technology market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global microbial fermentation technology market.

Table of Contents

1. Executive Summary

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Microbial Fermentation Technology Market

4. Market Overview

• 4.1. Market Segmentation
  • 4.1.1. Segment Definition
  • 4.1.2. Industry Evolution / Developments
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Microbial Fermentation Technology Market Analysis and Forecast, 2022-2031

5. Key Insights

• 5.1. Pipeline Analysis
• 5.2. COVID-19 Pandemic Impact on Industry

6. Microbial Fermentation Technology Market Analysis and Forecast, by Product

• 6.1. Introduction and Definitions
• 6.2. Key Findings/Developments
• 6.3. Market Value Forecast, by Product, 2017-2031
  • 6.3.1. Medical
    • 6.3.1.1. Antibiotics
    • 6.3.1.2. Probiotics
    • 6.3.1.3. Monoclonal Antibodies
    • 6.3.1.4. Recombinant Proteins
    • 6.3.1.5. Other Biosimilars
  • 6.3.2. Industrial
    • 6.3.2.1. Acetone, Ethanol & Butanol
    • 6.3.2.2. Enzymes & Amino Acids
  • 6.3.3. Alcoholic Beverages
    • 6.3.3.1. Beer
    • 6.3.3.2. Spirits
    • 6.3.3.3. Wine
    • 6.3.3.4. Others
  • 6.3.4. Food & Feed Products
• 6.4. Market Attractiveness, by Product

7. Global Microbial Fermentation Technology Market Analysis and Forecast, by End-user Industry

• 7.1. Introduction and Definitions
• 7.2. Key Findings/Developments
• 7.3. Market Value Forecast, by End-user Industry, 2017-2031
  • 7.3.1. Biopharmaceutical
  • 7.3.2. Food & Feed
  • 7.3.3. Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs)
  • 7.3.4. Academic Research Institutes
  • 7.3.5. Others
• 7.4. Market Attractiveness, by End-user Industry

8. Global Microbial Fermentation Technology Market Analysis and Forecast, by Region

• 8.1. Key Findings
• 8.2. Market Value Forecast, by Region, 2017-2031
  • 8.2.1. North America
  • 8.2.2. Europe
  • 8.2.3. Asia Pacific
  • 8.2.4. Latin America
  • 8.2.5. Middle East & Africa
• 8.3. Market Attractiveness, by Region

9. North America Microbial Fermentation Technology Market Analysis and Forecast

• 9.1. Introduction
  • 9.1.1. Key Findings
• 9.2. Market Value Forecast, by Product, 2022-2031
  • 9.2.1. Medical
    • 9.2.1.1. Antibiotics
    • 9.2.1.2. Probiotics
    • 9.2.1.3. Monoclonal Antibodies
    • 9.2.1.4. Recombinant Proteins
    • 9.2.1.5. Other Biosimilars
  • 9.2.2. Industrial
    • 9.2.2.1. Acetone, Ethanol & Butanol
    • 9.2.2.2. Enzymes & Amino Acids
  • 9.2.3. Alcoholic Beverages
    • 9.2.3.1. Beer
    • 9.2.3.2. Spirits
    • 9.2.3.3. Wine
    • 9.2.3.4. Others
  • 9.2.4. Food & Feed Products
• 9.3. Market Value Forecast, by End-user Industry, 2022-2031
  • 9.3.1. Biopharmaceutical
  • 9.3.2. Food & Feed
  • 9.3.3. Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs)
  • 9.3.4. Academic Research Institutes
  • 9.3.5. Others
• 9.4. Market Value Forecast, by Country, 2022-2031
  • 9.4.1. U.S.
  • 9.4.2. Canada
• 9.5. Market Attractiveness Analysis
  • 9.5.1. By Product
  • 9.5.2. By End-user Industry
  • 9.5.3. By Country

10. Europe Microbial Fermentation Technology Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Key Findings
• 10.2. Market Value Forecast, by Product, 2022-2031
  • 10.2.1. Medical
    • 10.2.1.1. Antibiotics
    • 10.2.1.2. Probiotics
    • 10.2.1.3. Monoclonal Antibodies
    • 10.2.1.4. Recombinant Proteins
    • 10.2.1.5. Other Biosimilars
  • 10.2.2. Industrial
    • 10.2.2.1. Acetone, Ethanol & Butanol
    • 10.2.2.2. Enzymes & Amino Acids
  • 10.2.3. Alcoholic Beverages
    • 10.2.3.1. Beer
    • 10.2.3.2. Spirits
    • 10.2.3.3. Wine
    • 10.2.3.4. Others
  • 10.2.4. Food & Feed Products
• 10.3. Market Value Forecast, by End-user Industry, 2022-2031
  • 10.3.1. Biopharmaceutical
  • 10.3.2. Food & Feed
  • 10.3.3. Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs)
  • 10.3.4. Academic Research Institutes
  • 10.3.5. Others
• 10.4. Market Value Forecast, by Country/Sub-region, 2022-2031
  • 10.4.1. Germany
  • 10.4.2. U.K.
  • 10.4.3. France
  • 10.4.4. Italy
  • 10.4.5. Spain
  • 10.4.6. Rest of Europe
• 10.5. Market Attractiveness Analysis
  • 10.5.1. By Product
  • 10.5.2. By End-user Industry
  • 10.5.3. By Country/Sub-region

11. Asia Pacific Microbial Fermentation Technology Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast, by Product, 2022-2031
  • 11.2.1. Medical
    • 11.2.1.1. Antibiotics
    • 11.2.1.2. Probiotics
    • 11.2.1.3. Monoclonal Antibodies
    • 11.2.1.4. Recombinant Proteins
    • 11.2.1.5. Other Biosimilars
  • 11.2.2. Industrial
    • 11.2.2.1. Acetone, Ethanol & Butanol
    • 11.2.2.2. Enzymes & Amino Acids
  • 11.2.3. Alcoholic Beverages
    • 11.2.3.1. Beer
    • 11.2.3.2. Spirits
    • 11.2.3.3. Wine
    • 11.2.3.4. Others
  • 11.2.4. Food & Feed Products
• 11.3. Market Value Forecast, by End-user Industry, 2022-2031
  • 11.3.1. Biopharmaceutical
  • 11.3.2. Food & Feed
  • 11.3.3. Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs)
  • 11.3.4. Academic Research Institutes
  • 11.3.5. Others
• 11.4. Market Value Forecast, by Country/Sub-region, 2022-2031
  • 11.4.1. China
  • 11.4.2. Japan
  • 11.4.3. India
  • 11.4.4. Australia & New Zealand
  • 11.4.5. Rest of Asia Pacific
• 11.5. Market Attractiveness Analysis
  • 11.5.1. By Product
  • 11.5.2. By End-user Industry
  • 11.5.3. By Country/Sub-region

12. Latin America Microbial Fermentation Technology Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast, by Product, 2022-2031
  • 12.2.1. Medical
    • 12.2.1.1. Antibiotics
    • 12.2.1.2. Probiotics
    • 12.2.1.3. Monoclonal Antibodies
    • 12.2.1.4. Recombinant Proteins
    • 12.2.1.5. Other Biosimilars
  • 12.2.2. Industrial
    • 12.2.2.1. Acetone, Ethanol & Butanol
    • 12.2.2.2. Enzymes & Amino Acids
  • 12.2.3. Alcoholic Beverages
    • 12.2.3.1. Beer
    • 12.2.3.2. Spirits
    • 12.2.3.3. Wine
    • 12.2.3.4. Others
  • 12.2.4. Food & Feed Products
• 12.3. Market Value Forecast, by End-user Industry, 2022-2031
  • 12.3.1. Biopharmaceutical
  • 12.3.2. Food & Feed
  • 12.3.3. Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs)
  • 12.3.4. Academic Research Institutes
  • 12.3.5. Others
• 12.4. Market Value Forecast, by Country/Sub-region, 2022-2031
  • 12.4.1. Brazil
  • 12.4.2. Mexico
  • 12.4.3. Rest of Latin America
• 12.5. Market Attractiveness Analysis
  • 12.5.1. By Product
  • 12.5.2. By End-user Industry
  • 12.5.3. By Country/Sub-region

13. Middle East & Africa Microbial Fermentation Technology Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast, by Product, 2022-2031
  • 13.2.1. Medical
    • 13.2.1.1. Antibiotics
    • 13.2.1.2. Probiotics
    • 13.2.1.3. Monoclonal Antibodies
    • 13.2.1.4. Recombinant Proteins
    • 13.2.1.5. Other Biosimilars
  • 13.2.2. Industrial
    • 13.2.2.1. Acetone, Ethanol & Butanol
    • 13.2.2.2. Enzymes & Amino Acids
  • 13.2.3. Alcoholic Beverages
    • 13.2.3.1. Beer
    • 13.2.3.2. Spirits
    • 13.2.3.3. Wine
    • 13.2.3.4. Others
  • 13.2.4. Food & Feed Products
• 13.3. Market Value Forecast, by End-user Industry, 2022-2031
  • 13.3.1. Biopharmaceutical
  • 13.3.2. Food & Feed
  • 13.3.3. Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs)
  • 13.3.4. Academic Research Institutes
  • 13.3.5. Others
• 13.4. Market Value Forecast, by Country/Sub-region, 2022-2031
  • 13.4.1. GCC Countries
  • 13.4.2. South Africa
  • 13.4.3. Rest of Middle East & Africa
• 13.5. Market Attractiveness Analysis
  • 13.5.1. By Product
  • 13.5.2. By End-user Industry
  • 13.5.3. By Country/Sub-region

14. Competition Landscape

• 14.1. Market Player - Competition Matrix (By Tier and Size of Companies)
• 14.2. Market Share Analysis, by Company (2022)
• 14.3. Company Profiles
  • 14.3.1. Biocon
    • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.1.2. Product Portfolio
    • 14.3.1.3. Financial Overview
    • 14.3.1.4. SWOT Analysis
    • 14.3.1.5. Strategic Overview
  • 14.3.2. Danone Limited
    • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.2.2. Product Portfolio
    • 14.3.2.3. Financial Overview
    • 14.3.2.4. SWOT Analysis
    • 14.3.2.5. Strategic Overview
  • 14.3.3. Lonza
    • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.3.2. Product Portfolio
    • 14.3.3.3. Financial Overview
    • 14.3.3.4. SWOT Analysis
    • 14.3.3.5. Strategic Overview
  • 14.3.4. United Breweries Ltd.
    • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.4.2. Product Portfolio
    • 14.3.4.3. Financial Overview
    • 14.3.4.4. SWOT Analysis
    • 14.3.4.5. Strategic Overview
  • 14.3.5. Amyris
    • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.5.2. Product Portfolio
    • 14.3.5.3. Financial Overview
    • 14.3.5.4. SWOT Analysis
    • 14.3.5.5. Strategic Overview
  • 14.3.6. Novozymes
    • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.6.2. Product Portfolio
    • 14.3.6.3. Financial Overview
    • 14.3.6.4. SWOT Analysis
    • 14.3.6.5. Strategic Overview
  • 14.3.7. TerraVia Holdings, Inc.
    • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.7.2. Product Portfolio
    • 14.3.7.3. Financial Overview
    • 14.3.7.4. SWOT Analysis
    • 14.3.7.5. Strategic Overview
  • 14.3.8. BioVectra
    • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.8.2. Product Portfolio
    • 14.3.8.3. Financial Overview
    • 14.3.8.4. SWOT Analysis
    • 14.3.8.5. Strategic Overview
  • 14.3.9. DSM
    • 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.9.2. Product Portfolio
    • 14.3.9.3. Financial Overview
    • 14.3.9.4. SWOT Analysis
    • 14.3.9.5. Strategic Overview
  • 14.3.10. F. Hoffmann La-Roche Ltd.
    • 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.10.2. Product Portfolio
    • 14.3.10.3. Financial Overview
    • 14.3.10.4. SWOT Analysis
    • 14.3.10.5. Strategic Overview